These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5495795)

  • 1. [Serologic survey of children in Mexico City. IV. Study of measles antibodies].
    Gutiérrez G; Ruiz-Gómez J; Bustamante ME; Alvarez MT
    Gac Med Mex; 1970 Nov; 100(11):1169-84. PubMed ID: 5495795
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
    Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
    J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measles vaccination using Schwarz strain: clinical, serologic and electroencephalographic study].
    Fourrier A; Beaussart M; Camier P; Lacombe A
    Pediatrie; 1969; 24(1):97-8. PubMed ID: 5385115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serologic survey in children of Mexico City. VII. Study of antibodies against Entamoeba histolytica].
    Gutiérrez-Trujillo G; Aubanel M
    Arch Invest Med (Mex); 1972; 2():Suppl 2:371-6. PubMed ID: 4349098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination against measles with Schwarz vaccine. Clinical, serologic and electroencephalographic results in 50 children].
    Fourrier A; Beaussart M; Camier P; Lacombe A
    Lille Med; 1968 Oct; 13(8):848-63. PubMed ID: 5743597
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elimination of indigenous measles transmission in England and Wales.
    Ramsay ME; Jin L; White J; Litton P; Cohen B; Brown D
    J Infect Dis; 2003 May; 187 Suppl 1():S198-207. PubMed ID: 12721914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of 3 measles vaccines. IV. Evaluation of effectiveness on the basis of epidemiologic observations].
    Przegl Epidemiol; 1971; 25(1):1-10. PubMed ID: 5088689
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI; Nakamura MA; Godoy MV; Kuri P; Lucas CA; Conyer RT
    J Infect Dis; 2004 May; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
    Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
    Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of accurate diagnosis in the assessment of impact of immunisation campaigns: case study of a measles immunisation programme in Madagascar.
    Garry SF
    Public Health; 2009 Jan; 123(1):72-3. PubMed ID: 19049839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 16. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
    Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
    East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal age for vaccinating Zimbabwean children against measles. 1. Maternal and transplacentally transmitted measles antibodies in infancy.
    Mhere OT; Mhlanga GE; Spencer HR
    Cent Afr J Med; 1984 Oct; 30(10):187-9. PubMed ID: 6518490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.